|
 |
| home > pmps > autumn 2001 > preparing for and responding to changes in ownership of your outsource provider |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Imagine that you are in charge of a multi-million Dollar product, which is critical to your company's future. It was your choice to outsource - your career seems to be on the fast track and nothing can stop you now. Until you hear that the outsource provider you selected has just been acquired or has announced a merger. You begin wondering what will happen to your career.
While this analogy may make light of a potentially serious issue, the fact remains that there have been a plethora of contract parenteral facilities in the US which have changed ownership in the last few years. In this relatively short period of time, Ben Venue, Catalytica, CBL, SP, Cook Pharmaceutical Systems, and most recently PDC, have all announced that they have been acquired or have otherwise changed ownership. This comes at a time when the contract industry is experiencing record growth and revenue levels.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Clinical Trials in CNS
25-26 November 2008, Copthorne Tara Hotel, London, UK
SMi present their 7th annual conference… Clinical Trials in CNS 25th to 26th November 2008, Copthorne Tara Hotel, London, UK
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
 |
